Tyrosine Kinase Inhibitors. 20. Optimization of Substituted Quinazoline and Pyrido[3,4-d]pyrimidine Derivatives as Orally Active, Irreversible Inhibitors of the Epidermal Growth Factor Receptor Family

Overview of attention for article published in Journal of Medicinal Chemistry, August 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (76th percentile)
Good Attention Score compared to outputs of the same age and source (67th percentile)

So far, Dimensions has found 44 publications that cite this research output.

Article in Bioorganic & Medicinal Chemistry (October 2022)

Article in Frontiers in Chemistry (June 2022)

Article in European Journal of Medicinal Chemistry (April 2022)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.